Aneuxral en es it fr

Aneuxral Brand names, Aneuxral Analogs

Aneuxral Brand Names Mixture

  • No information avaliable

Aneuxral Chemical_Formula


Aneuxral RX_link

No information avaliable

Aneuxral fda sheet

Aneuxral msds (material safety sheet)

Aneuxral Synthesis Reference

No information avaliable

Aneuxral Molecular Weight

309.469 g/mol

Aneuxral Melting Point

< 25 oC

Aneuxral H2O Solubility

Soluble as HCl salt

Aneuxral State


Aneuxral LogP


Aneuxral Dosage Forms

Tablets (oral, 1 mg)

Aneuxral Indication

Used for the symptomatic treatment of parkinsonism.

Aneuxral Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Aneuxral Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Aneuxral side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Aneuxral Patient Information

Aneuxral Organisms Affected

Humans and other mammals